Sign in
SVNS Stock Price, Chart, Stats & News
Solvonis Therapeutics plc
Save
Solvonis Therapeutics plc (SVNS) does not currently pay a dividend.
11.57M
Market cap
–
Current P/E
–
Forward P/E
SVNS chart
1M
3M
1Y
5Y
Loading chart...
About
Industrials
Sector
Industrial - Machinery
Industry
Graft Polymer (UK) Plc, set to become Solvonis Therapeutics plc in January 2025, is dedicated to the research and development of advanced polymer modification technologies and techniques. Its operations span the United Kingdom, Slovenia, and across Europe. The company offers a diverse portfolio of specialized products: GRAFTABOND: A line of graft/block copolymers designed to robustly combine various polymers with materials such as fiberglass, carbon fiber, mineral and natural fillers, and even mixed polymer waste.
Similar securities
Based on sector and market capitalization
Report issue